New asthma drug trial seeks to tame Tough-to-Treat cases
NCT ID NCT07436221
Summary
This study is testing whether an investigational drug called AK139 can help control moderate to severe asthma. It will involve about 160 adults whose asthma is not fully controlled. Researchers will measure if the drug improves lung function and reduces airway inflammation, while closely checking for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
Shanghai, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Conditions
Explore the condition pages connected to this study.